Gene · 7185
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells. | Blood Adv | 2023 | 36521105 | PubTator, text mining | PubMed |
| Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. | J Exp Med | 2023 | 36515678 | PubTator, text mining | PubMed |
Exosomal long non-coding RNA TRAFD1-4:1 derived from fibroblast-like synoviocytes suppresses chondrocyte proliferation and migration by degrading cartilage extracellular matrix in rheumatoid arthritis. | Exp Cell Res | 2023 | 36481205 | PubTator, text mining | PubMed |
| Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. | Arthritis Rheumatol | 2023 | 36428281 | PubTator, text mining | PubMed |
| RNA m6 A methylation in cancer. | Mol Oncol | 2023 | 36260366 | PubTator, text mining | PubMed |
| A proteome-scale map of the SARS-CoV-2-human contactome. | Nat Biotechnol | 2023 | 36217029 | PubTator, text mining | PubMed |
| Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT. | Cancer Gene Ther | 2023 | 36064576 | PubTator, text mining | PubMed |
| Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus. | J Invest Dermatol | 2023 | 36049539 | PubTator, text mining | PubMed |
| Inflammation-related Gene Polymorphisms Associated With Childhood Acute Lymphoblastic Leukemia. | J Pediatr Hematol Oncol | 2023 | 36036499 | PubTator, text mining | PubMed |
| Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease. | J Crohns Colitis | 2023 | 35998097 | PubTator, text mining | PubMed |
| MicroRNA-204-5p: A pivotal tumor suppressor. | Cancer Med | 2023 | 35908280 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| Novel insight into the aetiology of rheumatoid arthritis gained by a cross-tissue transcriptome-wide association study. | RMD Open | 2022 | 37582060 | PubTator, text mining | PubMed |
| Early and late genome-wide gastric epithelial transcriptome response during infection with the human carcinogen Helicobacterpylori. | Cell Insight | 2022 | 37193047 | PubTator, text mining | PubMed |
| Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. | Pharmaceuticals (Basel) | 2022 | 36678502 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I. | Ann Clin Case Rep | 2022 | 36626569 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF-κB Signaling Pathway and Affecting the Apoptosis and Signal Transduction. | Genet Res (Camb) | 2022 | 36619898 | PubTator, text mining | PubMed |
| From targeted therapy to a novel way: Immunogenic cell death in lung cancer. | Front Med (Lausanne) | 2022 | 36619616 | PubTator, text mining | PubMed |
| Ameliorative Effect of Structurally Divergent Oleanane Triterpenoid, 3-Epifriedelinol from Ipomoea batatas against BPA-Induced Gonadotoxicity by Targeting PARP and NF-κB Signaling in Rats. | Molecules | 2022 | 36615482 | PubTator, text mining | PubMed |
| Immune activation of characteristic gut mycobiota Kazachstania pintolopesii on IL-23/IL-17R signaling in ankylosing spondylitis. | Front Cell Infect Microbiol | 2022 | 36605130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7185/papers?page=14